GlassScriptPhysician profile
Melinia J Honjo
NPI 1386713147
$1,460.88
in general payments reported to CMS, 2019-2025
20 companies · $1,060 in 2025
The $1,060 reported for 2025 was more than what 84% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $40.58 · 2024: $361 · 2025: $1,060.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,336 · Education: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,335.97 |
| Education | $124.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $274.30 | 2024-2025 | Tremfya, Simponi, Simponi Aria |
| Abbvie INC. | $199.41 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $114.91 | 2024-2025 | Dupixent, Libtayo |
| Organon LLC | $106.90 | 2025 | Vtama |
| Genzyme Corporation | $106.72 | 2025 | |
| Incyte Corporation | $106.45 | 2023-2025 | Opzelura |
| Ucb, INC. | $105.07 | 2025 | Bimzelx |
| Amgen INC. | $72.70 | 2024-2025 | Otezla, Otezla |
| Novartis Pharmaceuticals Corporation | $58.54 | 2025 | |
| Botanix Sb INC | $46.15 | 2025 | Sofdra |
| Lilly USA, LLC | $44.72 | 2024-2025 | Taltz |
| Revance Therapeutics, INC. | $44.64 | 2024 | Daxxify |
| Sun Pharmaceutical Industries INC. | $33.50 | 2025 | |
| Pfizer INC. | $29.76 | 2023-2024 | |
| Galderma Laboratories, L.P. | $28.43 | 2025 | Nemluvio, Aklief |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyowa Kirin, INC. | $24.21 | 2025 | |
| Arcutis Biotherapeutics, INC. | $24.01 | 2024 | Zoryve |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $19.14 | 2025 | Jublia |
| Solta Medical, A Division of Bausch Health US, LLC | $14.96 | 2024 | Clear+Brilliant |
| Mayne Pharma Commercial LLC | $6.36 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melinia Honjo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.